Red Door Wealth Management LLC Buys 321 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Red Door Wealth Management LLC raised its stake in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 1.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 21,659 shares of the company’s stock after acquiring an additional 321 shares during the quarter. Red Door Wealth Management LLC’s holdings in HCA Healthcare were worth $6,501,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. FMR LLC grew its holdings in HCA Healthcare by 322.3% in the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company’s stock valued at $1,276,909,000 after buying an additional 2,397,883 shares in the last quarter. Franklin Resources Inc. increased its position in HCA Healthcare by 11.7% during the third quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company’s stock worth $660,842,000 after acquiring an additional 174,946 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of HCA Healthcare by 2.8% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,487,367 shares of the company’s stock worth $604,511,000 after purchasing an additional 41,190 shares in the last quarter. Janus Henderson Group PLC raised its position in shares of HCA Healthcare by 12.0% in the third quarter. Janus Henderson Group PLC now owns 1,339,638 shares of the company’s stock valued at $544,467,000 after buying an additional 143,995 shares in the last quarter. Finally, Darsana Capital Partners LP grew its position in HCA Healthcare by 53.3% during the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after buying an additional 400,000 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $325.18 on Friday. The company’s fifty day moving average is $314.50 and its 200 day moving average is $352.84. HCA Healthcare, Inc. has a twelve month low of $278.68 and a twelve month high of $417.14. The stock has a market cap of $82.37 billion, a price-to-earnings ratio of 14.60, a P/E/G ratio of 1.08 and a beta of 1.64. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71.

Analyst Ratings Changes

Several analysts have recently issued reports on the company. Morgan Stanley reduced their target price on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. KeyCorp dropped their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Oppenheimer lifted their price objective on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research note on Monday, October 28th. Raymond James lowered HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. Finally, StockNews.com lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $385.27.

Read Our Latest Stock Report on HCA

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. This represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Recommended Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.